Table 3.
Top 20 KDs Based on an Overall Ranking Score Derived From 3 Data-Driven Criteria
| KD | Meta P Value for KDA | P Value for GWAS Enrichment | Meta P Value for Differential Expression | Score 1 (KDA Strength and Consistency) | Score 2 (Subnetwork Enrichment for CARDIoGRAM-C4D GWAS Signals) | Score 3 (Gene Expression Alterations Between CAD and Controls) | Summary Score |
|---|---|---|---|---|---|---|---|
| LUM | 5.74e−08 | 1.14e−03 | 1.38e−13 | 0.935 | 0.923 | 0.978 | 2.836 |
| COL1A1 | 4.13e−06 | 1.14e−03 | 1.55e−05 | 0.848 | 0.923 | 0.819 | 2.590 |
| DUSP6 | 1.35e−34 | 6.82e−03 | 1.00e−16 | 1.000 | 0.538 | 1.000 | 2.538 |
| HGD | 1.05e−08 | 1.14e−03 | 3.76e−02 | 0.957 | 0.923 | 0.616 | 2.496 |
| MSN | 7.30e−06 | 4.55e−03 | 4.44e−16 | 0.826 | 0.619 | 0.993 | 2.438 |
| CXCL12 | 2.28e−05 | 1.14e−03 | 1.62e−02 | 0.797 | 0.923 | 0.652 | 2.372 |
| DUSP1 | 2.77e−26 | 1.02e−02 | 2.46e−08 | 0.993 | 0.427 | 0.928 | 2.348 |
| GBP2 | 1.60e−07 | 3.41e−03 | 9.42e−04 | 0.920 | 0.698 | 0.725 | 2.343 |
| MTMR11 | 8.93e−07 | 1.14e−03 | 3.61e−01 | 0.913 | 0.923 | 0.486 | 2.322 |
| CCL18 | 1.39e−06 | 9.09e−03 | 8.61e−11 | 0.877 | 0.474 | 0.949 | 2.300 |
| SLIT3 | 2.04e−04 | 1.00e−03 | 2.44e−01 | 0.717 | 1.000 | 0.507 | 2.225 |
| GBP1 | 3.41e−08 | 1.82e−02 | 1.05e−11 | 0.942 | 0.226 | 0.964 | 2.132 |
| F2 | 4.22e−13 | 1.14e−03 | 9.53e−01 | 0.971 | 0.923 | 0.232 | 2.126 |
| COL4A2 | 4.04e−06 | 5.68e−03 | 1.94e−03 | 0.855 | 0.582 | 0.688 | 2.126 |
| LOXL2 | 1.68e−04 | 3.41e−03 | 2.96e−02 | 0.725 | 0.698 | 0.638 | 2.061 |
| CXCL10 | 2.74e−04 | 1.02e−02 | 3.37e−12 | 0.659 | 0.427 | 0.971 | 2.058 |
| ANXA3 | 3.06e−03 | 1.14e−03 | 7.02e−07 | 0.246 | 0.923 | 0.877 | 2.046 |
| SLC2A3 | 2.74e−04 | 7.95e−03 | 4.76e−07 | 0.652 | 0.500 | 0.884 | 2.036 |
| SHC1 | 4.26e−03 | 1.14e−03 | 1.32e−09 | 0.167 | 0.923 | 0.942 | 2.032 |
| STAT3 | 3.50e−03 | 1.00e−03 | 3.27e−05 | 0.210 | 1.000 | 0.812 | 2.022 |
CAD indicates coronary artery disease; CARDIoGRAM-C4D, Coronary Artery Disease Genome Wide Replication and Meta-Analysis Plus the Coronary Artery Disease Consortium; KDA, key driver analysis; and GWAS, genome-wide association studies.